U.S. flag An official website of the United States government

U.S. Food and Drug Administration
  1. Home
  2. Drug Databases
  3. Orange Book Home

Orange Book: Approved Drug Products with Therapeutic Equivalence Evaluations

Home | Back to Search Results

Product Details for ANDA 020374

Expand all

INPERSOL-LC/LM W/ DEXTROSE 1.5% IN PLASTIC CONTAINER (CALCIUM CHLORIDE; DEXTROSE; MAGNESIUM CHLORIDE; SODIUM CHLORIDE; SODIUM LACTATE)
18.4MG/100ML;1.5GM/100ML;5.08MG/100ML;538MG/100ML;448MG/100ML
Marketing Status: Discontinued
Active Ingredient: CALCIUM CHLORIDE; DEXTROSE; MAGNESIUM CHLORIDE; SODIUM CHLORIDE; SODIUM LACTATE
Proprietary Name: INPERSOL-LC/LM W/ DEXTROSE 1.5% IN PLASTIC CONTAINER
Dosage Form; Route of Administration: SOLUTION; INTRAPERITONEAL
Strength: 18.4MG/100ML;1.5GM/100ML;5.08MG/100ML;538MG/100ML;448MG/100ML
Reference Listed Drug: No
Reference Standard: No
TE Code: 
Application Number: A020374
Product Number: 001
Approval Date: Jun 13, 1994
Applicant Holder Full Name: FRESENIUS USA INC
Marketing Status:  Discontinued
Patent and Exclusivity Information
INPERSOL-LC/LM W/ DEXTROSE 2.5% IN PLASTIC CONTAINER (CALCIUM CHLORIDE; DEXTROSE; MAGNESIUM CHLORIDE; SODIUM CHLORIDE; SODIUM LACTATE)
18.4MG/100ML;2.5GM/100ML;5.08MG/100ML;538MG/100ML;448MG/100ML
Marketing Status: Discontinued
Active Ingredient: CALCIUM CHLORIDE; DEXTROSE; MAGNESIUM CHLORIDE; SODIUM CHLORIDE; SODIUM LACTATE
Proprietary Name: INPERSOL-LC/LM W/ DEXTROSE 2.5% IN PLASTIC CONTAINER
Dosage Form; Route of Administration: SOLUTION; INTRAPERITONEAL
Strength: 18.4MG/100ML;2.5GM/100ML;5.08MG/100ML;538MG/100ML;448MG/100ML
Reference Listed Drug: No
Reference Standard: No
TE Code: 
Application Number: A020374
Product Number: 002
Approval Date: Jun 13, 1994
Applicant Holder Full Name: FRESENIUS USA INC
Marketing Status:  Discontinued
Patent and Exclusivity Information
INPERSOL-LC/LM W/ DEXTROSE 3.5% IN PLASTIC CONTAINER (CALCIUM CHLORIDE; DEXTROSE; MAGNESIUM CHLORIDE; SODIUM CHLORIDE; SODIUM LACTATE)
18.4MG/100ML;3.5GM/100ML;5.08MG/100ML;538MG/100ML;448MG/100ML
Marketing Status: Discontinued
Active Ingredient: CALCIUM CHLORIDE; DEXTROSE; MAGNESIUM CHLORIDE; SODIUM CHLORIDE; SODIUM LACTATE
Proprietary Name: INPERSOL-LC/LM W/ DEXTROSE 3.5% IN PLASTIC CONTAINER
Dosage Form; Route of Administration: SOLUTION; INTRAPERITONEAL
Strength: 18.4MG/100ML;3.5GM/100ML;5.08MG/100ML;538MG/100ML;448MG/100ML
Reference Listed Drug: No
Reference Standard: No
TE Code: 
Application Number: A020374
Product Number: 003
Approval Date: Jun 13, 1994
Applicant Holder Full Name: FRESENIUS USA INC
Marketing Status:  Discontinued
Patent and Exclusivity Information
INPERSOL-LC/LM W/ DEXTROSE 4.25% IN PLASTIC CONTAINER (CALCIUM CHLORIDE; DEXTROSE; MAGNESIUM CHLORIDE; SODIUM CHLORIDE; SODIUM LACTATE)
18.4MG/100ML;4.25GM/100ML;5.08MG/100ML;538MG/100ML;448MG/100ML
Marketing Status: Discontinued
Active Ingredient: CALCIUM CHLORIDE; DEXTROSE; MAGNESIUM CHLORIDE; SODIUM CHLORIDE; SODIUM LACTATE
Proprietary Name: INPERSOL-LC/LM W/ DEXTROSE 4.25% IN PLASTIC CONTAINER
Dosage Form; Route of Administration: SOLUTION; INTRAPERITONEAL
Strength: 18.4MG/100ML;4.25GM/100ML;5.08MG/100ML;538MG/100ML;448MG/100ML
Reference Listed Drug: No
Reference Standard: No
TE Code: 
Application Number: A020374
Product Number: 004
Approval Date: Jun 13, 1994
Applicant Holder Full Name: FRESENIUS USA INC
Marketing Status:  Discontinued
Patent and Exclusivity Information
Back to Top